Related references
Note: Only part of the references are listed.Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study
Haiyan Cheng et al.
DIABETES CARE (2022)
Large-scale GWAS reveals genetic architecture of brain white matter microstructure and genetic overlap with cognitive and mental health traits (n=17,706)
Bingxin Zhao et al.
MOLECULAR PSYCHIATRY (2021)
Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement
Veronika W. Skrivankova et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism?
Andrea Giaccari et al.
DIABETES CARE (2021)
Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study
Geert Jan Biessels et al.
DIABETOLOGIA (2021)
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial
Daniel K. Burns et al.
LANCET NEUROLOGY (2021)
The trans-ancestral genomic architecture of glycemic traits
Ji Chen et al.
NATURE GENETICS (2021)
Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression
Urmo Vosa et al.
NATURE GENETICS (2021)
BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
Nour M. Moussa-Pacha et al.
MEDICINAL RESEARCH REVIEWS (2020)
Mendelian randomization study showed no causality between metformin use and lung cancer risk
Huaqiang Zhou et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2020)
Is Type 2 Diabetes Causally Associated With Cancer Risk? Evidence From a Two-Sample Mendelian Randomization Study
Shuai Yuan et al.
DIABETES (2020)
Evaluating the impact of AMPK activation, a target of metformin, on risk of cardiovascular diseases and cancer in the UK Biobank: a Mendelian randomisation study
Shan Luo et al.
DIABETOLOGIA (2020)
Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial
Tali Cukierman-Yaffe et al.
LANCET NEUROLOGY (2020)
Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study
Katherine Samaras et al.
DIABETES CARE (2020)
Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases
Jie Zheng et al.
NATURE GENETICS (2020)
The GTEx Consortium atlas of genetic regulatory effects across human tissues
Francois Aguet et al.
SCIENCE (2020)
Body mass index and all cause mortality in HUNT and UK Biobank studies: linear and non-linear mendelian randomisation analyses
Yi-Qian Sun et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study
Shiu Lun Au Yeung et al.
DIABETOLOGIA (2019)
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk
Iris E. Jansen et al.
NATURE GENETICS (2019)
ChEMBL: towards direct deposition of bioassay data
David Mendez et al.
NUCLEIC ACIDS RESEARCH (2019)
Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer's Disease
Elissa C. McIntosh et al.
DIABETES CARE (2019)
The Impact of Glycated Hemoglobin (HbA1c) on Cardiovascular Disease Risk: A Mendelian Randomization Study Using UK Biobank
Shiu Lun Au Yeung et al.
DIABETES CARE (2018)
Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function
Gail Davies et al.
NATURE COMMUNICATIONS (2018)
The MR-Base platform supports systematic causal inference across the human phenome
Gibran Hemani et al.
ELIFE (2018)
Aging as a Biological Target for Prevention and Therapy
Nir Barzilai et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis
Jared M. Campbell et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Lulu Sun et al.
NATURE MEDICINE (2018)
Growth Differentiation Factor 15 as a Novel Biomarker for Metformin
Hertzel C. Gerstein et al.
DIABETES CARE (2017)
Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption
Fernando Pires Hartwig et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
Reduced Mitochondrial Activity is Early and Steady in the Entorhinal Cortex but it is Mainly Unmodified in the Frontal Cortex in Alzheimer's Disease
Mercedes Armand-Ugon et al.
CURRENT ALZHEIMER RESEARCH (2017)
Metformin and ageing: improving ageing outcomes beyond glycaemic control
Willy Marcos Valencia et al.
DIABETOLOGIA (2017)
The pharmacogenetics of metformin
Jose C. Florez
DIABETOLOGIA (2017)
The mechanisms of action of metformin
Graham Rena et al.
DIABETOLOGIA (2017)
Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
Jack Bowden et al.
GENETIC EPIDEMIOLOGY (2016)
Antihypertensive Drugs, Prevention of Cognitive Decline and Dementia: A Systematic Review of Observational Studies, Randomized Controlled Trials and Meta-Analyses, with Discussion of Potential Mechanisms
Laure Rouch et al.
CNS DRUGS (2015)
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
Jack Bowden et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
The support of human genetic evidence for approved drug indications
Matthew R. Nelson et al.
NATURE GENETICS (2015)
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Anila K. Madiraju et al.
NATURE (2014)
Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
Claudia Giambartolomei et al.
PLOS GENETICS (2014)
Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease
Caroline L. Relton et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Robert Howard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Avoiding bias from weak instruments in Mendelian randomization studies
Stephen Burgess et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2011)
Donepezil in patients with severe Alzheimer's disease:: double-blind, parallel-group, placebo-controlled study
B Winblad et al.
LANCET (2006)
'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?
GD Smith et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2003)
Share Paper
